Light Horse Therapeutics Funding: $62M Raised, Series A
Light Horse Therapeutics is a Biotech company based in San Diego. It has raised $62M in total funding. Latest round: Series A.
Light Horse Therapeutics funding overview
Light Horse Therapeutics is a Biotech company based in San Diego. Light Horse Therapeutics has raised $62M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2024. The round record for Light Horse Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Versant Ventures, Mubadala Capital, Bristol-Myers Squibb, Taiho Ventures, AbbVie, Novartis Venture Fund. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Light Horse Therapeutics funding
How much has Light Horse Therapeutics raised?
Light Horse Therapeutics has raised $62M in total disclosed funding across the rounds on record.
Who has invested in Light Horse Therapeutics?
Versant Ventures, Mubadala Capital, Bristol-Myers Squibb, Taiho Ventures, AbbVie, Novartis Venture Fund are named among the investors backing Light Horse Therapeutics.
What was the latest Light Horse Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2024.
Where is Light Horse Therapeutics based?
Light Horse Therapeutics is based in San Diego.
What sector does Light Horse Therapeutics operate in?
Light Horse Therapeutics is tracked under Biotech from San Diego, with $62M in disclosed funding.
When did Light Horse Therapeutics last raise?
The last disclosed Light Horse Therapeutics round closed in August 2024 at Series A.
Totals shown for Light Horse Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Diego and the investors behind them below.
Companies related to Light Horse Therapeutics (40)
